TEAM

Member of the Board, CFO & General Manager of Finance & Administration Division
Katsuhisa Yamaguchi
After gaining experience in IPO support, tax, and audit services at a tax accounting firm and an audit firm, Katsuhisa Yamaguchi spent 17 years managing finance within pharmaceutical companies, serving as Finance Director at Chugai Pharma Europe & UK, Head of Accounting & Finance at GSK Japan, and CFO for Sandoz Japan, a division of the Novartis Group. As a Certified Public Accountant, he was engaged in auditing publicly listed companies in Japan at Asahi Audit Corporation (now KPMG Azsa LLC), and U.S. companies at KPMG in New York. He later served as Vice President of Finance at Asurion Group before joining Rege Nephro from its inception as CFO and General Manager of Finance & Administration. He has been appointed to the Board of Directors since December 2021. Katsuhisa holds a bachelor’s degree from Keio University and is a Certified Public Accountant.